These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 17969456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML, Rönnblom L.
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
    Mangini AJ, Lafyatis R, Van Seventer JM.
    Ann N Y Acad Sci; 2007 Jun; 1108():11-23. PubMed ID: 17893966
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT, Tzeng HT, Chen JY.
    Cells; 2019 Aug 23; 8(9):. PubMed ID: 31450787
    [Abstract] [Full Text] [Related]

  • 8. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK.
    Arthritis Rheumatol; 2016 Nov 23; 68(11):2686-2696. PubMed ID: 27338297
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD, Kuruganti S, Deshpande A, Goepfert PA, Chatham WW, Walter MR.
    Lupus; 2020 Aug 23; 29(9):1095-1105. PubMed ID: 32611267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.
    Kono DH, Baccala R, Theofilopoulos AN.
    Autoimmunity; 2003 Dec 23; 36(8):503-10. PubMed ID: 14984027
    [Abstract] [Full Text] [Related]

  • 16. Immunopathogenesis of systemic lupus erythematosus: An update.
    Arnaud L, Chasset F, Martin T.
    Autoimmun Rev; 2024 Oct 23; 23(10):103648. PubMed ID: 39343084
    [Abstract] [Full Text] [Related]

  • 17. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S, Meka S, Gamero AM.
    Cytokine; 2021 Oct 23; 146():155633. PubMed ID: 34340046
    [Abstract] [Full Text] [Related]

  • 18. Targeting of type I interferon in systemic autoimmune diseases.
    Crow MK, Olferiev M, Kirou KA.
    Transl Res; 2015 Feb 23; 165(2):296-305. PubMed ID: 25468480
    [Abstract] [Full Text] [Related]

  • 19. Type I Interferons in Autoimmune Disease.
    Crow MK, Olferiev M, Kirou KA.
    Annu Rev Pathol; 2019 Jan 24; 14():369-393. PubMed ID: 30332560
    [Abstract] [Full Text] [Related]

  • 20. The Type I Interferonopathies.
    Lee-Kirsch MA.
    Annu Rev Med; 2017 Jan 14; 68():297-315. PubMed ID: 27813875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.